(Q38760864)

26943780

6 September 2017

title

Rare neurological channelopathies--networks to study patients, pathogenesis and treatment (English)

1 reference

6 September 2017

Joanna C Jen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json

15 May 2020

Tetsuo Ashizawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json

15 May 2020

Robert C Griggs

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json

15 May 2020

Michael F Waters

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json

15 May 2020

language of work or name

English

0 references

publication date

4 March 2016

1 reference

26943780

6 September 2017

published in

Nature Reviews Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json

15 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json

15 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json

15 May 2020

page(s)

195-203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json

Clinical research for rare disease: opportunities, challenges, and solutions

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Unintended effects of orphan product designation for rare neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Challenges in the design and conduct of therapeutic trials in channel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Treatment of neuromuscular channelopathies: current concepts and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

The primary periodic paralyses: diagnosis, pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Identification of a mutation in the gene causing hyperkalemic periodic paralysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Dihydropyridine receptor mutations cause hypokalemic periodic paralysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

The skeletal muscle chloride channel in dominant and recessive human myotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Primary episodic ataxias: diagnosis, pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

A novel locus for episodic ataxia:UBR4 the likely candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Late onset hereditary episodic ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Mutations in KCND3 cause spinocerebellar ataxia type 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Rare disease centers for periodic paralysis: China versus the United States and United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Comprehensive phenotype of the p.Arg420his allelic form of spinocerebellar ataxia type 13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Oculomotor and visual axis systems sparing in spinocerebellar ataxia type 13(R420H).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Frequency of KCNC3 DNA Variants as Causes of Spinocerebellar Ataxia 13 (SCA13)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

KCNC3: phenotype, mutations, channel biophysics-a study of 260 familial ataxia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Identification of the cystic fibrosis gene: genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Exome sequencing in undiagnosed inherited and sporadic ataxias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

A new episodic ataxia syndrome with linkage to chromosome 19q13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Genetic heterogeneity of autosomal dominant nonprogressive congenital ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Episodic vertical oscillopsia with progressive gait ataxia: clinical description of a new episodic syndrome and evidence of linkage to chromosome 13q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

The status of telestroke in the United States: a survey of currently active stroke telemedicine programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Mexiletine for treatment of myotonia: a trial triumph for rare disease networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Scale for the assessment and rating of ataxia: development of a new clinical scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Spinocerebellar ataxias: genotype-phenotype correlations in 104 Brazilian families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

An interactive voice response diary for patients with non-dystrophic myotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Non-dystrophic myotonia: prospective study of objective and patient reported outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Haploinsuffciency for Znf9 in Znf9+/- mice is associated with multiorgan abnormalities resembling myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Large genomic deletions in CACNA1A cause episodic ataxia type 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Determining optimal therapy--randomized trials in individual patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.18

31 March 2020

Identifiers

DOI

10.1038/NRNEUROL.2016.18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json

Dimensions Publication ID

15 May 2020

1045883803

0 references

Fatcat ID

release_qszzz6iz3ffm7lhnm553qihoru

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qszzz6iz3ffm7lhnm553qihoru

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json

15 May 2020

26943780

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6609097&resulttype=core&format=json